| http://www.w3.org/ns/prov#value | - x Demonstrates Superiority of in Delivering An Effective Multi-Drug Inhaled Dose Compared to Conventional Formulation Notice of Annual General Meeting of Karo Bio AB Pulmatrix's PUR118 Demonstrates Potential to Reduce Acute Exacerbations of the Lung Associated with Progressive Respiratory Diseases, such as COPD, Asthma, CF, and Respiratory Infections Meet the New Allenex AB in Stockholm, May 15 at
|
